What does CUSIP 803607100 represent in this 13F holders report?

CUSIP 803607100 is the security identifier for SRPT - Sarepta Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held SRPT - Sarepta Therapeutics, Inc. - Common Stock in Q3 2023?

390 institutional investors reported SRPT - Sarepta Therapeutics, Inc. - Common Stock for Q3 2023. Use the holders table for investor-level position and value details.

Sarepta Therapeutics, Inc. - Common Stock (SRPT)

CUSIP: 803607100

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock
Shares outstanding: 105,070,763
Total 13F shares: 83,265,476
Share change: +1,516,485
Total reported value: $10,092,124,857
Put/Call ratio: 84%
Price per share: $121.22
Number of holders: 390
Value change: +$213,088,130
Number of buys: 193
Number of sells: 178

Quarterly Holders Quick Answers

What is CUSIP 803607100?
CUSIP 803607100 identifies SRPT - Sarepta Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 803607100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SRPT - Sarepta Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	8.1%	8,531,479	$977,024,976	—	30 Jun 2023	13F
BlackRock Finance, Inc.	13F	Company	5.2%	5,503,466	$630,256,925	—	30 Jun 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	5.2%	5,447,667	$623,869,537	—	30 Jun 2023	13F
Avoro Capital Advisors LLC	13F	Company	4.4%	4,627,888	$529,985,734	—	30 Jun 2023	13F
JPMORGAN CHASE & CO	13F	Company	4.2%	4,404,093	$504,356,754	—	30 Jun 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.7%	3,855,102	$441,486,282	—	30 Jun 2023	13F
EcoR1 Capital, LLC	13F	Company	3.5%	3,660,798	$419,234,587	—	30 Jun 2023	13F
Bank of New York Mellon Corp	13F	Company	2.3%	2,432,768	$278,600,645	—	30 Jun 2023	13F
STATE STREET CORP	13F	Company	1.8%	1,913,732	$219,160,589	—	30 Jun 2023	13F
FMR LLC	13F	Company	1.7%	1,803,828	$206,574,348	—	30 Jun 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	1,388,083	$158,963,339	—	30 Jun 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.2%	1,289,198	$147,638,955	—	30 Jun 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	1.2%	1,259,434	$144,230,382	—	30 Jun 2023	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.1%	1,205,200	$138,019,504	—	30 Jun 2023	13F
DEUTSCHE BANK AG\	13F	Company	1.1%	1,106,702	$126,739,513	—	30 Jun 2023	13F
Casdin Capital, LLC	13F	Company	0.97%	1,015,000	$116,237,800	—	30 Jun 2023	13F
MORGAN STANLEY	13F	Company	0.93%	976,350	$111,811,671	—	30 Jun 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.92%	969,288	$111,002,886	—	30 Jun 2023	13F
FEDERATED HERMES, INC.	13F	Company	0.92%	964,947	$110,505,730	—	30 Jun 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.91%	953,003	$109,137,904	—	30 Jun 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.85%	890,713	$102,004,453	—	30 Jun 2023	13F
NORGES BANK	13F	Company	0.79%	830,624	$95,123,060	—	30 Jun 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.74%	780,921	$89,432,000	—	30 Jun 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.73%	766,193	$87,744,411	—	30 Jun 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.69%	725,787	$83,117,127	—	30 Jun 2023	13F
Erste Asset Management GmbH	13F	Company	0.69%	720,860	$82,327,486	—	30 Jun 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.62%	655,000	$75,010,600	—	30 Jun 2023	13F
ORBIMED ADVISORS LLC	13F	Company	0.62%	654,000	$74,896,080	—	30 Jun 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.61%	642,078	$73,531,000	—	30 Jun 2023	13F
FIRST TRUST ADVISORS LP	13F	Company	0.58%	604,336	$69,208,541	—	30 Jun 2023	13F
Boxer Capital, LLC	13F	Company	0.57%	600,000	$68,712,000	—	30 Jun 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.56%	593,354	$67,950,900	—	30 Jun 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.56%	588,011	$67,339,020	—	30 Jun 2023	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.55%	575,782	$65,938,572	—	30 Jun 2023	13F
Capital Research Global Investors	13F	Company	0.53%	557,383	$63,831,501	—	30 Jun 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.53%	554,042	$63,448,890	—	30 Jun 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.52%	542,912	$62,174,355	—	30 Jun 2023	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	0.48%	508,845	$58,272,929	—	30 Jun 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.48%	501,301	$57,408,991	—	30 Jun 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.43%	449,104	$51,431,390	—	30 Jun 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.42%	445,573	$51,027,020	—	30 Jun 2023	13F
Artisan Partners Limited Partnership	13F	Company	0.42%	440,871	$50,488,547	—	30 Jun 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.41%	432,744	$49,558,000	—	30 Jun 2023	13F
Rock Springs Capital Management LP	13F	Company	0.4%	425,000	$48,671,000	—	30 Jun 2023	13F
NORTHERN TRUST CORP	13F	Company	0.39%	410,555	$47,016,759	—	30 Jun 2023	13F
LORD, ABBETT & CO. LLC	13F	Company	0.38%	402,566	$46,102,000	—	30 Jun 2023	13F
Camber Capital Management LP	13F	Company	0.38%	400,000	$45,808,000	—	30 Jun 2023	13F
BARCLAYS PLC	13F	Company	0.38%	398,525	$45,639,083	—	30 Jun 2023	13F
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC	13F	Company	0.33%	348,595	$39,921,099	—	30 Jun 2023	13F
Invesco Ltd.	13F	Company	0.33%	341,550	$39,114,307	—	30 Jun 2023	13F

Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q3 2023

As of 30 Sep 2023, Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by 390 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 83,265,476 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, STATE STREET CORP, FMR LLC, and T. Rowe Price Investment Management, Inc.. This page lists 390 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

399

Q3 2023 holders

390

Holder diff

-9

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.